RESUMEN
INTRODUCTION: This article offers a systematic literature review (SLR) on the use of the MiniMed 780G automated insulin delivery system (MM780G) in people with type 1 diabetes (PwT1D) during Ramadan intermittent fasting. It also presents consensus recommendations on the use of MM780G during the Ramadan period. METHODS: The SLR was performed following PRISMA methodology. The recommendations resulted from a consensus-forming process involving a panel of experts. The process considered evidence found in the SLR as well as the expert opinions. RESULTS: In total, 6 studies were included in the SLR. The evidence and expert opinions led to recommendations related to a) pre-Ramadan counseling of MM780G users who plan to fast, b) suggested MM780G settings, meal announcement strategy and safety aspects during Ramadan (including a contingency plan), and c) post-Ramadan transition into and out of Eid-al-Fitr festivities. DISCUSSION: The SLR findings showed that the MM780G maintain glycemic control at target in PwT1D during Ramadan (meeting CGM-based clinical targets proposed by the International Consensus on Time-in-Range) while ensuring low rates of hypoglycemia and diabetic ketoacidosis. Automated insulin delivery also helps PwT1D fast more days of Ramadan compared to users of other less advanced modalities of treatment. Pre-Ramadan guidance on specific aspects of the MM780G along with IDF-DAR counseling guidelines are recommended. There is still a challenge with post-Iftar hyperglycemia, which could potentially be mitigated by following the recommendations outlined in this article.